Evidence check: Skincare DNA in the context of longevity

Skincare DNA tests (e.g., genes for collagen, antioxidant defense, or UV sensitivity) are often marketed with longevity claims. However, the scientific evidence is weak: most studies are small, unreplicated, or show only statistical associations without clinical relevance. Direct proof that such tests extend lifespan or significantly slow skin aging is lacking. Mechanistically, links are plausible (e.g., collagen gene variants and skin elasticity), but the translation to individual longevity is unclear. Moreover, many providers overstate the predictive power of single SNPs. For evidence-based longevity strategies, lifestyle factors (diet, exercise, sun protection) and clinical biomarkers (e.g., HbA1c, CRP) are currently more relevant than skin DNA tests. Conclusion: marketing outweighs evidence; tests may satisfy curiosity but should not guide medical decisions.